Stem cell-based therapies for neurodegenerative diseases aim at halting clinical
deterioration by regeneration and by providing local support for damaged tissue …

β2 integrins are heterodimeric surface receptors composed of a variable α (CD11a-CD11d)
and a constant β (CD18) subunit and are specifically expressed by leukocytes. The α …

Neurodegenerative disorders are a variety of diseases including Alzheimer's (AD),
Parkinson's (PD), and Huntington's diseases (HD), multiple sclerosis (MS) and amyotrophic …

Multiple sclerosis (MS) is an autoimmune, demyelinating disease of the central nervous
system. Nowadays, available therapies for MS can help to manage MS course and …

Mesenchymal stem/stromal cells (MSCs) are isolated from various fetal and adult tissues
such as bone marrow, adipose tissue, cord blood and placenta. Placental MSCs (pMSCs) …

Background: One of the greatest challenges for medicine is to find a safe and effective
treatment for immune-related diseases. However, due to the low efficacy of the treatment …

Abstract Background Mesenchymal stem cells (MSCs) have been extensively explored as a
promising therapeutic agent in the field of bone tissue engineering due to their osteogenic …

Background Multiple sclerosis (MS) is an autoimmune inflammatory disease of the central
nervous system (CNS). MS affects millions of people and causes a great economic and …

The placenta is a temporary organ that is discarded after birth and is one of the most
promising sources of various cells and tissues for use in regenerative medicine and tissue …

The autoimmune diseases are characterized by overactivation of immune cells, chronic
inflammation, and immune response to self-antigens, leading to the damage and …